This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Wnt | |
|---|---|
![]() | |
| Name | Wnt |
| Discovery | 0 1982 |
| Family | Secreted glycoproteins |
| Genes | WNT1, WNT2, WNT3, WNT3A, WNT4, WNT5A, WNT5B, WNT6, WNT7A, WNT7B, WNT8A, WNT8B, WNT9A, WNT9B, WNT10A, WNT10B, WNT11, WNT16 |
| Receptors | Frizzled family, LRP5, LRP6, ROR1, ROR2, RYK |
| Species | Metazoa |
Wnt Wnt proteins are a conserved family of secreted signaling glycoproteins that regulate cell fate, polarity, proliferation, migration, and stem cell behavior across metazoan species. Originating from genetic and biochemical studies linked to oncogenesis and embryogenesis, Wnt ligands engage multiple receptor systems to activate canonical and noncanonical intracellular cascades that influence morphogenesis in organisms studied by laboratories affiliated with institutions such as Harvard University, Stanford University, Max Planck Society, Cold Spring Harbor Laboratory, and European Molecular Biology Laboratory.
Wnt signaling was first implicated by genetic experiments in model organisms including Drosophila and vertebrate systems influenced by investigators at University of Cambridge and Yale University, with landmark associations to oncogenic processes described in collaborations involving National Institutes of Health researchers. The pathway integrates extracellular cues through receptors like Frizzled and coreceptors studied alongside components such as β-catenin, APC, GSK3β, and Axin, with perturbations linked to pathologies investigated by groups at MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center. Comparative genomics across taxa including Caenorhabditis elegans, Mus musculus, Danio rerio, Xenopus laevis, and Homo sapiens has revealed conserved ligand repertoires and divergent functional specializations explored by consortia like the Human Genome Project and the ENCODE Project.
Wnt proteins are typically 350–400 amino acids with conserved motifs and post-translational lipidation mediated by Porcupine (PORCN), secretion facilitated by Wntless (WLS), and extracellular binding to heparan sulfate proteoglycans such as Syndecan and Glypican. The WNT gene family includes paralogs WNT1–WNT16 studied in phylogenetics by teams from Howard Hughes Medical Institute and annotated in databases maintained by National Center for Biotechnology Information and Ensembl. Structural studies leveraging techniques from X-ray crystallography, cryo-electron microscopy, and computational modeling performed at institutions like California Institute of Technology and Swiss Federal Institute of Technology have characterized Wnt–Frizzled interfaces and lipid modifications analogous to findings from investigations of Hedgehog and TGF-β families.
Canonical Wnt signaling stabilizes β-catenin permitting nuclear interaction with transcription factors such as TCF/LEF and coactivators studied in developmental labs at University of Oxford and University College London. Noncanonical pathways include planar cell polarity (PCP) and Wnt/Ca2+ routes involving proteins like Dishevelled (DVL), RhoA, Rac1, JNK, and PKC, with mechanistic overlaps examined by researchers at Johns Hopkins University and University of California, San Francisco. Receptor complexes incorporating LRP5, LRP6, ROR1, ROR2, and RYK determine pathway bias, a subject of pharmacologic modulation pursued in collaborations between Pfizer, Roche, and academic centers such as Massachusetts Institute of Technology.
Wnt signaling governs axis formation in embryos of Xenopus, somitogenesis in Danio rerio, neural crest development studied by groups at Columbia University, limb patterning explored at University of Chicago, and hair follicle cycling investigated at University of Pennsylvania. In adult tissues, Wnt ligands regulate intestinal stem cell niches characterized by markers like Lgr5 examined by teams at Sanger Institute and control hematopoietic stem cell behavior analyzed at Fred Hutchinson Cancer Center. Roles in synaptogenesis connect Wnt activity to research from MIT Media Lab adjunct labs and neuroscience centers including Salk Institute.
Wnt pathways are modulated by antagonists such as DKK1, SFRP family members, and Notum, and intersect with signaling networks like Notch, Hedgehog, BMP, FGF, EGF, and TNFα pathways researched at collaborative centers including Wellcome Trust-funded initiatives. Post-translational control via ubiquitin ligases (e.g., RNF43, ZNRF3), deubiquitinases, phosphorylation by CK1α and GSK3β, and proteolytic processing integrate inputs from metabolic regulators including mTOR and hypoxia-responsive factors studied at Karolinska Institute.
Aberrant Wnt signaling contributes to colorectal cancer driven by mutations in APC and CTNNB1 reported by consortia such as The Cancer Genome Atlas and clinical centers like Cleveland Clinic. Additional associations include hepatocellular carcinoma, triple-negative breast cancer, ovarian cancer, prostate cancer, and desmoid tumors investigated across oncology networks including European Society for Medical Oncology and American Society of Clinical Oncology. Mutations in components such as LRP5 affect bone density disorders characterized in studies from University of Helsinki and Mayo Clinic, while dysregulation links to neurodegenerative diseases like Alzheimer's disease examined at Banner Alzheimer's Institute and fibrotic conditions studied by groups at Imperial College London. Therapeutic strategies target PORCN inhibitors, monoclonal antibodies against Frizzled receptors, and small molecules modulating β-catenin being trialed in collaborations between Novartis, AstraZeneca, and academic medical centers.
Experimental investigation employs genetic models including knockout mice generated at facilities like Jackson Laboratory, CRISPR/Cas9 editing developed with contributions from Broad Institute, in vitro assays using organoids pioneered at Hubrecht Institute and Brigham and Women's Hospital, reporter constructs such as TOPFlash/TOPGAL, biochemical ligand–receptor binding assays, single-cell RNA sequencing platforms from 10x Genomics, proteomics pipelines using mass spectrometry developed at ProteomeXchange-linked centers, and imaging methods including confocal microscopy popularized by groups at NIH and EMBL. High-throughput screens for modulators use compound libraries supplied by organizations such as Chemical Biology Consortium and link to translational programs at Cancer Research UK.
Category:Signaling proteins